In the recent PAR008 release PAR management claimed that there was not just cartilage preservation but growth. This is unheard of in any OA medication study.
So why is there a lack of scientific or media interest?
Why is there a lack of exuberance in the AGM on this point?
Why is there an increase in short interest?
Why would non-executive directors leave?
Why the lack of peer review that has always been promised, for a number of years?
- Forums
- ASX - By Stock
- PAR
- If the claim is....then why ?
If the claim is....then why ?
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.31M |
Open | High | Low | Value | Volume |
28.0¢ | 29.0¢ | 25.0¢ | $738.1K | 2.730M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 156142 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 54972 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 155839 | 0.250 |
7 | 93180 | 0.245 |
9 | 60893 | 0.240 |
7 | 105094 | 0.235 |
14 | 143914 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 51469 | 7 |
0.260 | 47026 | 4 |
0.265 | 265979 | 7 |
0.270 | 31481 | 5 |
0.285 | 83782 | 5 |
Last trade - 13.37pm 18/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |